Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Recurrent herpes simplex: the outlook for systemic antiviral agents.

× No keyword cloud information.

21 in total

1. Herpes simplex virus DNA and mRNA sequences in acutely and chronically infected trigeminal ganglia of mice.

Authors: A Puga; J D Rosenthal; H Openshaw; A L Notkins
Journal: Virology Date: 1978-08 Impact factor: 3.616

2. Thymidine kinase from herpes simplex virus phosphorylates the new antiviral compound, 9-(2-hydroxyethoxymethyl)guanine.

Authors: J A Fyfe; P M Keller; P A Furman; R L Miller; G B Elion
Journal: J Biol Chem Date: 1978-12-25 Impact factor: 5.157

3. Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine.

Authors: G B Elion; P A Furman; J A Fyfe; P de Miranda; L Beauchamp; H J Schaeffer
Journal: Proc Natl Acad Sci U S A Date: 1977-12 Impact factor: 11.205

4. Effect of 9-(2-hydroxyethoxymethyl)guanine on herpesvirus-induced keratitis and iritis in rabbits.

Authors: H E Kaufman; E D Varnell; Y M Centifanto; S D Rheinstrom
Journal: Antimicrob Agents Chemother Date: 1978-12 Impact factor: 5.191

5. Viral-specific thymidine kinase in sensory ganglia of mice infected with herpes simplex virus.

Authors: H Yamamoto; M A Walz; A L Notkins
Journal: Virology Date: 1977-02 Impact factor: 3.616

6. Latent herpes simplex virus infections in sensory ganglia of hairless mice prevented by acycloguanosine.

Authors: R J Klein; A E Friedman-Kien; E DeStefano
Journal: Antimicrob Agents Chemother Date: 1979-05 Impact factor: 5.191

7. Herpetic ganglionic latency. Aciclovir and vidarabine therapy.

Authors: D Pavan-Langston; N H Park; J H Lass
Journal: Arch Ophthalmol Date: 1979-08

8. (E)-5-(2-Bromovinyl)-2'-deoxyuridine: a potent and selective anti-herpes agent.

Authors: E De Clercq; J Descamps; P De Somer; P J Barr; A S Jones; R T Walker
Journal: Proc Natl Acad Sci U S A Date: 1979-06 Impact factor: 11.205

9. (E)-5-(2-bromovinyl)-2'-Deoxyuridine in the treatment of experimental herpes simplex keratitis.

Authors: P C Maudgal; E De Clercq; J Descamps; L Missotten; P De Somer; R Busson; H Vanderhaeghe; G Verhelst; R T Walker; A S Jones
Journal: Antimicrob Agents Chemother Date: 1980-01 Impact factor: 5.191

10. Effect of acycloguanosine treatment of acute and latent herpes simplex infections in mice.

Authors: H J Field; S E Bell; G B Elion; A A Nash; P Wildy
Journal: Antimicrob Agents Chemother Date: 1979-04 Impact factor: 5.191

8 in total

Review 1. The pathogenesis of acute, latent and recurrent herpes simplex virus infections.

Authors: R J Klein
Journal: Arch Virol Date: 1982 Impact factor: 2.574

Review 2. Herpes simplex virus and the nervous system.

Authors: P G Kennedy
Journal: Postgrad Med J Date: 1984-04 Impact factor: 2.401

3. Effect of discontinuous acyclovir treatment on in vitro reactivation of herpes simplex virus from latently infected trigeminal ganglia.

Authors: R J Klein; A E Friedman-Kien; E DeStefano
Journal: Antimicrob Agents Chemother Date: 1983-07 Impact factor: 5.191

4. Efficacy of the acyclic nucleoside 9-(1,3-dihydroxy-2-propoxymethyl)guanine against primary and recrudescent genital herpes simplex virus type 2 infections in guinea pigs.

Authors: E B Fraser-Smith; D F Smee; T R Matthews
Journal: Antimicrob Agents Chemother Date: 1983-12 Impact factor: 5.191

8. Activity of 1-(2'-fluoro-2'-deoxy-beta-D-arabinofuranosyl)thymine against herpes simplex virus in cell cultures and rabbit eyes.

Authors: M D Trousdale; A B Nesburn; T L Su; C Lopez; K A Watanabe; J J Fox
Journal: Antimicrob Agents Chemother Date: 1983-06 Impact factor: 5.191